Cornell scientists have developed a new technique for imaging a zebrafish’s brain at all stages of its development, which could have implications for the study of human brain disorders, including autism.
A Cornell faculty member is part of a core team that has organized the Tompkins County COVID-19 Food Task Force, a nerve center working to ensure that those in need have access to food and that food producers stay in operation during the crisis.
Cornell mathematicians are using game theory to model how the competition between cancer cells can be leveraged, so cancer treatment – which takes a toll on the patient’s body – might be administered more sparingly, with maximized effect.
A Cornell senior research associate served as a consultant to members of the New York State Senate on the Outdoor Rx Act, a bill that seeks to make it easier for veterans to access New York state’s scenic and restorative outdoor spaces.
Professionals from Cayuga Health have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New Yorkers diagnosed with COVID-19.
How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.
COVID-19 patients experience a wide range of disease severity. Why do some people get severe and life-threatening illness, while others suffer no symptoms or just mild ones?
Researchers show that the wallflower is an excellent model plant for discovering new cardenolides that could be used to treat heart disease and cancer.
The Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from COVID-19 and identify new cases of it.
